ストックスクリーナーアプリを入手
1.25
1.63%
0.02
アフターアワーズ：
1.26
0.01
+0.80%
前日終値:
$1.23
開ける：
$1.21
24時間の取引高:
97,477
Relative Volume:
0.07
時価総額：
$4.98M
収益：
$32.96M
当期純損益:
$-4.23M
株価収益率:
-0.00805
EPS:
-155.3294
ネットキャッシュフロー:
$-14.00M
1週間 パフォーマンス:
-8.76%
1か月 パフォーマンス:
-15.54%
6か月 パフォーマンス:
-53.53%
1年 パフォーマンス:
-93.15%
1日の値動き範囲:
$1.21
$1.2798
1週間の範囲:
$1.21
$1.385
52週間の値動き範囲:
$1.1693
$23.20
Sunshine Biopharma Inc Stock (SBFM) Company Profile
名前
Sunshine Biopharma Inc
セクター
電話
954-515-0810
住所
333 LAS OLAS WAY, FORT LAUDERDALE
SBFM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SBFM
Sunshine Biopharma Inc
|
1.25 | 4.98M | 32.96M | -4.23M | -14.00M | -155.33 |
|
ZTS
Zoetis Inc
|
159.27 | 70.23B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.74 | 48.23B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.36 | 48.22B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.93 | 18.57B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.42 | 13.29B | 2.76B | 1.11B | 898.10M | 22.77 |
Sunshine Biopharma Inc (SBFM) 最新ニュース
Sunshine Biopharma launches generic antipsychotic drug - Investing.com Australia
Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia - GuruFocus
Sunshine Biopharma (SBFM) Unveils Generic Antipsychotic Drug in Canada | SBFM Stock News - GuruFocus
Sunshine Biopharma launches generic antipsychotic drug By Investing.com - Investing.com India
Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market - ACCESS Newswire
Sunshine Biopharma Challenges $1.2B Antipsychotic Market With New Generic Latuda Alternative - Stock Titan
Certain Warrants of Sunshine Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 4-MAY-2025. - marketscreener.com
Sunshine Biopharma Inc’s Market Journey: Closing Weak at 1.84, Down -18.22 - DWinneX
Sunshine Biopharma (NASDAQ:SBFMW) Stock Price Down 4.5% – Here’s Why - Defense World
There is no doubt that Sunshine Biopharma Inc (SBFM) ticks all the boxes. - Sete News
Sunshine Becomes Latest To Compete On Everolimus In Canada - insights.citeline.com
Sunshine Biopharma Boosts Retail Trader Appeal After Canadian Launch Of Generic Cancer Drug - Asianet Newsable
Sunshine Biopharma Boosts Retail Trader Appeal After Canadian Launch Of Generic Cancer Drug By Stocktwits - Investing.com India
SBFM Stock: A Comprehensive Analysis and Forecast - investchronicle.com
Sunshine Biopharma enters Canadian generic drug market with Everolimus By Investing.com - Investing.com South Africa
Press Release Distribution & PR Platform - ACCESS Newswire
SBFM’s valuation metrics: A comprehensive analysis - uspostnews.com
Sunshine Biopharma (SBFM) Finalizes $2.46 Million Stock Offering - GuruFocus
Sunshine Biopharma Unit Rolls Out Afinitor Alternative Everolimus in Canadian Market - marketscreener.com
Sunshine Biopharma enters Canadian generic drug market with Everolimus - Investing.com
Sunshine Biopharma (SBFM) Launches Generic Everolimus in Canada | SBFM Stock News - GuruFocus
Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion | SBFM Stock News - GuruFocus
Major Cancer Treatment Everolimus Enters Canadian Market: Multiple Cancer Types Targeted in $2.5B Opportunity - Stock Titan
Sunshine Biopharma (SBFM) Launches Generic Everolimus in Canada - GuruFocus
Sunshine Biopharma stock hits 52-week low at $1.24 - Investing.com Australia
Sunshine Biopharma stock hits 52-week low at $1.24 By Investing.com - Investing.com India
Sunshine Biopharma (NASDAQ:SBFMW) Trading Down 10.9% – Here’s Why - Defense World
Sunshine Biopharma stock hits 52-week low at $1.85 amid steep decline By Investing.com - Investing.com South Africa
Sunshine Biopharma Secures $2.46 Million in Direct Offering - TipRanks
Sunshine Biopharma Closes $2.5 Million Direct Offering - MarketScreener
Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering - ACCESS Newswire
SEC Form 424B5 filed by Sunshine Biopharma Inc. - Quantisnow
Sunshine Biopharma stock hits 52-week low at $1.85 amid steep decline - Investing.com India
Sunshine Biopharma’s K1.1-mRNA-LNP shows promise in HCC mouse model - BioWorld MedTech
The time has not yet come to remove your chips from the table: Sunshine Biopharma Inc (SBFM) - Sete News
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Sunshine Biopharma secures $2.46 million in stock offering By Investing.com - Investing.com Canada
Sunshine Biopharma Reports 78% Revenue Growth and Key Developments in 2022 - TipRanks
Sunshine Biopharma (SBFM) Reports Increased Revenue Despite Net Loss - GuruFocus
Sunshine Biopharma (SBFM) Secures $2.46 Million in Direct Stock Offering - GuruFocus
Sunshine Biopharma secures $2.46 million in stock offering - Investing.com
Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules - ACCESS Newswire
Sunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drug - Benzinga
Biotech Stock Sunshine Biopharma Inc. (NASDAQ:SBFM) Makes NASDAQ Top Gainer List on News - Investorideas.com
This Pharma Stock Is Gaining Major Steam Ahead Of Opening Bell - The Globe and Mail
From Underdog to Top Performer: Sunshine Biopharma’s Impressive Surge - timothysykes.com
Sunshine Biopharma (SBFM) Announces Promising Results for Liver Cancer Treatment - GuruFocus
Sunshine Biopharma reports progress in liver cancer treatment - Investing.com India
Sunshine Biopharma Completes Additional Studies of mRNA Therapy for Liver Cancer; Shares Up Pre-Bell - MarketScreener
Pre-market Movers: IBG, JYD, SBFM, SPWH, RSLS… - RTTNews
Revolutionary mRNA Treatment Succeeds Against Deadly Liver Cancer in Latest Trial - Stock Titan
Sunshine Biopharma Inc (SBFM) 財務データ
収益
当期純利益
現金流量
EPS
0.82%
1.62%
大文字化:
|
ボリューム (24 時間):